HAIIKU29 Dreamcatcher is an indica dominant hybrid with lineage including Holy Grail Kush & Blue Dream. HAIIKU29 contains 29% THC, making this strain an ideal choice for experienced medicinal cannabis patients. 

This potent cultivar boasts large aesthetic buds, thick with sticky trichome cover. The trichome sheen highlights the tight trim and the vibrant-looking orange and deep purple of the glossy dried flowers.

HAIIKU29 is craft grown, hang dried and hand trimmed to ensure quality flower presentation. With a unique terpene profile of 2.61% HAIIKU29 offers a pungent aroma including nutty pine and petroleum, with a hint of lemons.

HAIIKU29 is paired with a unique terpene profile including:

Limonene

Beta-Myrcene

Trans-Caryophyllene

Farnesene

Alpha-Humulene 

Alpha-Bisabolol

Beta-Pinene

Linalool

Alpha-Terpineol

Alpha-Pinene 

Camphene

Caryophyllene Oxide

Terpinolene

Trans-Nerolidol

Borneol 

Medigrowth is driven by passion and the pursuit of excellence in cannabinoid medicine. As a fully licenced Australian

medicinal cannabis biotech, our success is measured in real world change: improving lives for Australian patients and

delivering results as a trusted B2B, research and medical partner.

—

Patients, doctors & pharmacists can find further information on Medigrowth Australia and how to legally access

medicinal cannabis products at medigrowth.com.au.

Total terpenes: 2.61%

Minor cannabinoids include: CBGA, CBCA, THCVA, CBG, CBDA